TABOMEDEX BIOSCIENCES, INC.

tabomedex-biosciences-inc-logo

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes. They mainly study the mechanism of action of MK2 and achieve the effect of controlling blood glucose level by inhibiting MK2, namely inhibiting the effect of downstream avtivating enzymes.

#SimilarOrganizations #People #Financial #Website #More

TABOMEDEX BIOSCIENCES, INC.

Industry:
Biotechnology Health Care Medical

Founded:
2013-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.tabomedex.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
5 M USD

Technology used in webpage:
Euro Squarespace Hosted


Similar Organizations

clene-nanomedicine-logo

Clene Nanomedicine

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

not_available_image

D2M Biotherapeutics

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

impact-biomedicines-logo

Impact Biomedicines

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Employees Featured

not_available_image

Ira Tabas
Ira Tabas Co-Founder @ Tabomedex Biosciences, Inc.
Co-Founder

lale-ozcan_image

Lale Ozcan
Lale Ozcan Co-Founder @ Tabomedex Biosciences, Inc.
Co-Founder

Founder


not_available_image

Ira Tabas

lale-ozcan_image

Lale Ozcan

Investors List

viva-biotech_image

Viva BioInnovator

Viva BioInnovator investment in Series A - Tabomedex Biosciences, Inc.

jmcr-partners_image

JMCR Partners

JMCR Partners investment in Series A - Tabomedex Biosciences, Inc.

viva-ventures-biotech-group_image

Viva Ventures Biotech Fund

Viva Ventures Biotech Fund investment in Series A - Tabomedex Biosciences, Inc.

Official Site Inspections

http://www.tabomedex.com Semrush global rank: 9.07 M Semrush visits lastest month: 445

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Tabomedex Biosciences, Inc."

Tabomedex

Tabomedex Biosciences. Supporting your path to health. OUR TEAM. Ira Tabas, PhD ...See details»

Tabomedex Biosciences, Inc. - Crunchbase Company โ€ฆ

Organization. Tabomedex Biosciences, Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โ€ฆSee details»

OUR TEAM - Tabomedex

Ira tabas, phD Dr. Tabas is the Richard J. Stock Professor of Medicine and Cell Biology at . Columbia University. His research focuses on (1) molecular-cellular mechanismsSee details»

Tabomedex 2025 Company Profile: Valuation, Investors โ€ฆ

Tabomedex General Information Description. Operator of a novel therapeutics company intended to work on research and development of new drugs related to type 2 diabetes. The company is engaged in the development of MK2 which โ€ฆSee details»

Tabomedex Biosciences, Inc. - Funding, Financials, Valuation

Tabomedex Biosciences, Inc. is funded by 3 investors. Viva BioInnovator and JMCR Partners are the most recent investors. Unlock for free . ... How much funding has this organization raised โ€ฆSee details»

Tabomedex - Products, Competitors, Financials, Employees, โ€ฆ

Tabomedex Biosciences is a company focused on biomedical research in the healthcare sector. They specialize in studying the mechanisms of diabetes and obesity to develop potential โ€ฆSee details»

Tabomedex Biosciences - Company Profile - Tracxn

Feb 8, 2025 Tabomedex Biosciences is developing therapies for treating diabetes. The lead candidate of the company is a protein kinase inhibitor (Mitogen-activated protein kinase โ€ฆSee details»

Tabomedex - Org Chart, Teams, Culture & Jobs - The Org

View Tabomedex's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»

Tabomedex Biosciences, Inc. - Contacts, Employees, Board โ€ฆ

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes.See details»

TABOMEDEX BIOSCIENCES, LLC :: Massachusetts (US)

Jul 29, 2013 Recent filings for TABOMEDEX BIOSCIENCES, LLC. 5 Jul 2017. Certificate of Merger - Unregistered Foreign. 15 Jun 2017. 2017 Annual Report. 27 Jun 2016. 2016 Annual โ€ฆSee details»

Tabomedex Biosciences, Inc. - Drug pipelines, Patents ... - Patsnap

100 Clinical Results associated with Tabomedex Biosciences, Inc. Login to view more data. 0 Patents (Medical) associated with Tabomedex Biosciences, Inc. ... The statistics for drugs in โ€ฆSee details»

Tabomedex Biosciences, Inc. - Crunchbase

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes.See details»

Tabomedex Biosciences - Overview, News & Similar companies

Tabomedex Biosciences LLC is a company that operates in the Biotechnology industry. It employs 6-10 people and has $0M-$1M of revenue. The company is headquartered in โ€ฆSee details»

Tabomedex BioSciences - Viva BioInnovator

Tabomedex is developing new mechanism with an allosteric kinase inhibitor for diabetes treatment. Links. About us Portfolio Team News Contact Us. Our Address. Viva BioInnovator. โ€ฆSee details»

Ira Tabas, MD, PhD, Columbia University

In both the atherosclerosis and metabolism areas, there is strong emphasis on therapeutic translation. In this context, Dr. Tabas is co-founder of Tabomedex Biosciences, LLC, which is โ€ฆSee details»

Patents Assigned to Tabomedex Biosciences, LLC

Jul 19, 2018 Patents Assigned to Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof. Patent number: 10562909 Abstract: Provided โ€ฆSee details»

Tabomedex Biosciences, Inc. (Tabomedex Biosciences, Inc.) - ่ฏ็‰ฉ โ€ฆ

ไบ†่งฃTabomedex Biosciences, Inc. (Tabomedex Biosciences, Inc.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„๏ผŒ็–พ็—…้ข†ๅŸŸ:ๅ†…ๅˆ†ๆณŒไธŽไปฃ่ฐข็–พ็—…๏ผŒๆŠ€ๆœฏๅนณๅฐ:ๅฐๅˆ†ๅญๅŒ–่ฏ๏ผŒ่ฏ็‰ฉ:TBX-2๏ผŒTBX โ€ฆSee details»

Tabomedex - F6S

Claim the Tabomedex page . Claim page This page was created when someone associated with Tabomedex joined F6S. Verified Tabomedex employees can claim the page to update itSee details»

Series A - Tabomedex Biosciences, Inc. - 2020-08-03 - Crunchbase

Edit Overview Section. Organization Name . Tabomedex Biosciences, Inc.See details»

Tabomedex Biosciences, Inc. - Tech Stack, Apps, Patents

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes.See details»

linkstock.net © 2022. All rights reserved